Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisporivir + Ribavirin in HCV GT2/3 Interferon-Failures
NCT02094443Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Mar 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of alisporivir in hepatitis C (HCV), sponsored by Debiopharm. Started Mar 2014; status: completed.
02
Drugs
alisporivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02094443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094443.